Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/43041
Campo DC Valoridioma
dc.contributor.authorNaranjo, Antonio
dc.contributor.authorOjeda-Bruno, Soledad
dc.contributor.authorBilbao Cantarero, Ana
dc.contributor.authorQuevedo Abeledo, Juan Carlos
dc.contributor.authorHenríquez-Hernández, Luis Alberto
dc.contributor.authorRodríguez-Lozano, Carlos
dc.contributor.otherNaranjo Hernandez, Antonio
dc.contributor.otherHenriquez-Hernandez, Luis Alberto
dc.date.accessioned2018-11-21T12:13:22Z-
dc.date.available2018-11-21T12:13:22Z-
dc.date.issued2014
dc.identifier.issn1699-258X
dc.identifier.urihttp://hdl.handle.net/10553/43041-
dc.description.abstractObjective: To assess the influence of the implementation of a program for secondary prevention of osteoporotic fractures on prescribing bisphosphonates and persistent short-term treatment. Patients and methods: Patients >. 50 years with fragility fracture attended in the emergency department were enrolled in an observational study. The program consisted of: 1) training of primary care physicians, 2) baseline visit: questionnaire on osteoporosis, bone densitometry and patient education, 3) patient referral to primary care, except those with multiple fractures or requiring special study or therapy, who were referred to a specialist, and 4) follow-up by checking prescriptions in electronic records, and a telephone survey. The outcome variable was the percentage of patients who, on having been prescribed bisphosphonates, still adhered to the treatment at 3 months. Results: Of the 532 patients with inclusion criteria, 202 (39%) refused to participate. Those who refused to take part had a higher mean age (P<. .01) and a higher frequency of hip fracture (P<. .01) compared with patients who did participate. A total of 330 patients were included for intervention, with a mean age of 71 years, and 254(77%) were female. An antiresorptive was being used by 45 patients (13%) at baseline. After the baseline visit 223 patients (67%) were recommended a bisphosphonate. In the follow-up at 3 months 78% of patients who had been prescribed bisphosphonate were still receiving treatment. Conclusions: We present a multidisciplinary program for secondary prevention of fractures coordinated by rheumatology in which the number of patients who were receiving bisphosphonate at 3 months increased by four times compared to baseline visit. © 2013 Elsevier España, S.L.U.
dc.publisher1699-258X
dc.relation.ispartofReumatologia Clinica
dc.sourceReumatologia Clinica[ISSN 1699-258X],v. 10 (5), p. 299-303
dc.titleResults of a model of secondary prevention for osteoporotic fracture coordinated by rheumatology and focused on the nurse and primary care physicians
dc.typeinfo:eu-repo/semantics/Articlees
dc.typeArticlees
dc.identifier.doi10.1016/j.reuma.2013.12.007
dc.identifier.scopus84906790010-
dc.identifier.isi000421428100006
dcterms.isPartOfReumatologia Clinica
dcterms.sourceReumatologia Clinica[ISSN 1699-258X],v. 10 (5), p. 299-303
dc.contributor.authorscopusid7003297397
dc.contributor.authorscopusid6602428868
dc.contributor.authorscopusid7801311085
dc.contributor.authorscopusid55295814500
dc.contributor.authorscopusid15829708200
dc.contributor.authorscopusid6603136298
dc.description.lastpage303
dc.description.firstpage299
dc.relation.volume10
dc.type2Artículoes
dc.identifier.wosWOS:000421428100006
dc.contributor.daisngid550893
dc.contributor.daisngid4801071
dc.contributor.daisngid8143522
dc.contributor.daisngid7862165
dc.contributor.daisngid465624
dc.contributor.daisngid1048977
dc.identifier.investigatorRIDE-7910-2010
dc.identifier.investigatorRIDNo ID
dc.date.coverdateEnero 2014
dc.identifier.ulpgces
dc.description.esciESCI
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Grupo de investigaciones infecciosas, nutricionales e inflamatorias en pacientes hospitalarios / Study Group on infectious, nutritional and inflammatory diseases in hospitalized patients-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.deptGIR IUIBS: Medio Ambiente y Salud-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.orcid0000-0002-2013-6664-
crisitem.author.orcid0000-0003-3237-0316-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameNaranjo Hernández, Antonio-
crisitem.author.fullNameHenríquez Hernández, Luis Alberto-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

21
actualizado el 17-nov-2024

Citas de WEB OF SCIENCETM
Citations

22
actualizado el 17-nov-2024

Visitas

31
actualizado el 08-jul-2023

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.